TY  - BOOK
ED  - United States.
TI  - Examining patient access to investigational drugs: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017
AV  - KF27 .E553 2017o
PY  - 2018///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - United States
KW  - Food and Drug Administration
KW  - Clinical trials
KW  - Moral and ethical aspects
KW  - Drugs
KW  - Testing
KW  - Legislative hearings
KW  - lcgft
N1  - "Serial No. 115-60."; CRDP Program record; Includes bibliographical references
UR  - https://purl.fdlp.gov/GPO/gpo113883
ER  -